Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

High-content tripartite split-GFP cell-based assays to screen for modulators of small GTPase activation.

Koraïchi F, Gence R, Bouchenot C, Grosjean S, Lajoie-Mazenc I, Favre G, Cabantous S.

J Cell Sci. 2018 Jan 8;131(1). pii: jcs210419. doi: 10.1242/jcs.210419.

2.

Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity.

Pich C, Teiti I, Sarrabayrouse G, Gallardo F, Gence R, Tilkin-Mariamé AF.

PLoS One. 2016 Feb 1;11(2):e0148095. doi: 10.1371/journal.pone.0148095. eCollection 2016.

3.

In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.

Teiti I, Florie B, Pich C, Gence R, Lajoie-Mazenc I, Rochaix P, Favre G, Tilkin-Mariamé AF.

Front Oncol. 2015 Jul 14;5:156. doi: 10.3389/fonc.2015.00156. eCollection 2015.

4.

Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.

Chinestra P, Olichon A, Medale-Giamarchi C, Lajoie-Mazenc I, Gence R, Inard C, Ligat L, Faye JC, Favre G.

PLoS One. 2014 Nov 3;9(11):e111034. doi: 10.1371/journal.pone.0111034. eCollection 2014.

Supplemental Content

Support Center